Teamwork Financial Advisors LLC Decreases Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Teamwork Financial Advisors LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 25.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,920 shares of the biotechnology company’s stock after selling 2,752 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in Axon Enterprise were worth $4,707,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of AXON. Dimensional Fund Advisors LP increased its holdings in Axon Enterprise by 10.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock worth $54,874,000 after purchasing an additional 17,905 shares during the last quarter. Canada Pension Plan Investment Board raised its holdings in Axon Enterprise by 81.0% in the second quarter. Canada Pension Plan Investment Board now owns 5,067 shares of the biotechnology company’s stock valued at $1,491,000 after acquiring an additional 2,267 shares in the last quarter. AE Wealth Management LLC boosted its stake in Axon Enterprise by 24.8% during the 2nd quarter. AE Wealth Management LLC now owns 831 shares of the biotechnology company’s stock valued at $245,000 after acquiring an additional 165 shares during the last quarter. ProShare Advisors LLC grew its holdings in Axon Enterprise by 9.2% during the 2nd quarter. ProShare Advisors LLC now owns 9,798 shares of the biotechnology company’s stock worth $2,883,000 after acquiring an additional 826 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its position in shares of Axon Enterprise by 79.5% in the 2nd quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock worth $766,000 after purchasing an additional 1,153 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on AXON shares. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Stock Up 0.3 %

AXON opened at $607.60 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67. The stock’s 50 day moving average price is $617.26 and its 200 day moving average price is $466.40. The stock has a market cap of $46.33 billion, a P/E ratio of 157.00, a P/E/G ratio of 6.07 and a beta of 1.04.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 over the last ninety days. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.